Ypsilanti, MI, United States of America

Joel Kennard

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Wacker Chemie Ag. Active years: 2022.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Joel Kennard

Introduction

Joel Kennard is an accomplished inventor based in Ypsilanti, MI (US). He has made significant contributions to the field of chemistry, particularly through his innovative work on crosslinkable compositions. His expertise and creativity have led to the development of a patent that showcases his skills as an inventor.

Latest Patents

Joel Kennard holds a patent for crosslinkable compositions. This invention is designed to enhance the properties of materials, making them more versatile and effective in various applications. His patent is a testament to his dedication to advancing technology and improving existing solutions.

Career Highlights

Throughout his career, Joel has been associated with Wacker Chemie AG, a leading company in the chemical industry. His role at the company has allowed him to work on cutting-edge projects and contribute to the development of innovative products. With a total of 1 patent, he has established himself as a valuable asset in his field.

Collaborations

Joel has collaborated with talented coworkers, including Christine Klingler and Kathleen Beekel. These partnerships have fostered a creative environment that encourages the exchange of ideas and the pursuit of groundbreaking innovations.

Conclusion

In summary, Joel Kennard is a notable inventor whose work on crosslinkable compositions has made a significant impact in the field of chemistry. His contributions, along with his collaborations, highlight the importance of innovation in driving progress within the industry.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…